Regional Analysis

Global Sanger Sequencing Market Regional Insights

To learn more about this report, Request sample copy

North America remains the dominant region in the global sanger sequencing market and is anticipated to hold 43.2% of the market share in 2024. Key market players operating in sanger sequencing such as Thermo Fisher Scientific Inc. and Illumina, Inc. have their headquarters in the U.S. These companies invest heavily in research and development. Several top universities and research institutions routinely employ Sanger sequencing for their research. This academic research further strengthens commercial applications and services in the country. The size and expertise of the biotechnology industry in the U.S. encourages continued adoption of Sanger sequencing tools and services in applications such as nucleic acid analysis, genetic testing, and forensics.

The Asia Pacific region has been witnessing impressive growth and is emerging as the fastest growing regional market for the sanger sequencing market. Rapid economic development and rising healthcare expenditures have increased investments towards biomedical research and clinical diagnostics in several Asia Pacific countries. The genomics markets in China and India in particular are experiencing high growth driven by government initiatives to support precision medicine and biotechnology industries. Local Sanger sequencing companies in China and other Asian countries also offer highly competitive prices, making the region an attractive outsourcing destination for sequencing services. Furthermore, fall in reagent costs over the years has enabled greater accessibility to Sanger sequencing tools in price-sensitive markets. This is evidenced by increasing Sanger sequencing instrument sales as well as import-export trade volumes within the Asia Pacific region. The above factors will likely contribute to Asia Pacific outpacing other geographic markets in terms of Sanger sequencing adoption and revenues in the coming years.